TABLE 1.
Phaco and TrabEx+(n=45) | TrabEx+ Standalone (n=28) | P | |
---|---|---|---|
Age, years | 70.4±11.2 | 65.4±16.8 | 0.2* |
Sex, female (%) | 22 (49) | 16 (57) | 0.5† |
Left eye (%) | 22 (49) | 12 (43) | 0.6† |
Secondary glaucoma (%) | 15 (33) | 15 (54) | 0.09† |
Latest follow-up, months | 16.0±9.9 | 16.4±11.0 | 0.9* |
BCVA gain, Snellen lines | 1.2±2.2 | −0.6±2.4 | <0.001‡ |
Preoperative IOP, mm Hg | 30.4±7.8 | 32.9±6.1 | 0.15* |
Latest IOP, mm Hg | 18.3±7.1 | 25.0±13.2 | 0.02* |
Pre op IOP medication | 2.8±1.2 | 3.0±1.1 | 0.5‡ |
Latest IOP medication | 1.8±1.3 | 2.0±1.4 | 0.5‡ |
Independent Samples t test.
χ2 test.
Mann-Whitney U test.
BCVA indicates best corrected visual acuity; IOP, intraocular pressure.